GlassScriptPhysician profile
Marc T Civitano
NPI 1578615621
$2,751.26
in general payments reported to CMS, 2019-2025
23 companies · $462 in 2025
The $462 reported for 2025 was more than what 79% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $713 · 2022: $765 · 2023: $450 · 2024: $361 · 2025: $462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,272.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,182.68 | 2021-2024 | Mako, Motionsense Digital Goniometer, Accolade |
| Smith+Nephew, INC. | $496.85 | 2021-2025 | N/A, Healicoil |
| Depuy Synthes Sales INC. | $190.90 | 2021-2025 | Monovisc |
| Zimmer Biomet Holdings, INC. | $182.22 | 2021-2025 | Persona, Tapestry, Comprehensive Shoulder System |
| Gotham Surgical Solutions & Devices, INC. | $120.93 | 2024-2025 | |
| Endo Pharmaceuticals INC. | $75.19 | 2022-2024 | Xiaflex |
| Convatec INC. | $57.70 | 2021 | |
| Nevro Corp. | $55.13 | 2021-2023 | Senza |
| Ethicon US, LLC | $52.29 | 2021-2025 | Surgicel Nu-Knit, Stratafix |
| Treace Medical Concepts, INC. | $42.64 | 2025 | |
| Linkbio Corp | $36.48 | 2025 | |
| Si-Bone, INC. | $32.25 | 2025 | |
| Medtronic, INC. | $26.09 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $24.55 | 2024 | Iovera, Zilretta, Exparel |
| Sanara Medtech INC. | $24.39 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $24.11 | 2021 | |
| Ibsa Pharma INC. | $23.64 | 2022 | |
| Heron Therapeutics, INC. | $23.38 | 2023 | Zynrelef |
| Amgen INC. | $21.33 | 2022 | |
| Fidia Pharma USA INC. | $16.65 | 2025 | Triluron, Hymovis |
| Kowa Pharmaceuticals America, INC. | $15.94 | 2023 | Seglentis |
| Vericel Corporation | $13.01 | 2022 | |
| Zimvie INC. | $12.91 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Civitano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.